| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/06/2001 | WO2001047546A3 Methods and products for tumor immunotherapy using cytokines |
| 12/06/2001 | WO2001045741A3 Methods for preparing pharmaceutical formulations |
| 12/06/2001 | WO2001041734A3 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 12/06/2001 | WO2001041702A3 Zinc thiosalicylate, dermatological compositions containing same, in particular in the form of a self-adhesive device and method for preparing same |
| 12/06/2001 | WO2001039752A3 Transdermal therapeutic system containing highly volatile active ingredients |
| 12/06/2001 | WO2001035867A3 Ophthalmologic implant |
| 12/06/2001 | WO2001034647A3 Animal collagens and gelatins |
| 12/06/2001 | WO2001034646A3 Recombinant gelatins |
| 12/06/2001 | WO2001034130A9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 12/06/2001 | WO2001032146A3 Amphiphilic polymeric vesicles |
| 12/06/2001 | WO2001032031A3 Cholesterol reducing sterol compositions, preparation and method of use |
| 12/06/2001 | WO2001028526A3 Gastroresistant tablets for alimentary, dietetic and therapeutic use |
| 12/06/2001 | WO2001025390B1 Water unstable foam compositions |
| 12/06/2001 | WO2001024788A3 Treating endometriosis or infertility, or improving fertility |
| 12/06/2001 | WO2001023362A3 Rate-controlled particles |
| 12/06/2001 | WO2001013884A3 Cosmetic and/or pharmaceutical preparations with polymers containing polysiloxanes and the uses thereof |
| 12/06/2001 | WO2001007015A3 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates |
| 12/06/2001 | WO2000064427A3 Lamivudine containing pharmaceutical formulation |
| 12/06/2001 | WO2000006599A8 Inhibitors of hiv membrane fusion |
| 12/06/2001 | WO1995034292A3 Stabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluids |
| 12/06/2001 | US20010049546 Multi-purpose drug and heat therapy treatment system |
| 12/06/2001 | US20010049489 Pellet implant system for immediate and delayed release of antiparasitic drug |
| 12/06/2001 | US20010049442 Paroxetine compositions |
| 12/06/2001 | US20010049439 Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same |
| 12/06/2001 | US20010049417 Hydrogels containing substances |
| 12/06/2001 | US20010049396 Symptomatic relief |
| 12/06/2001 | US20010049391 Tramadol or a pharmaceutically acceptable derivative or salt thereof and a carrier |
| 12/06/2001 | US20010049386 Method of treating onychomycosis |
| 12/06/2001 | US20010049383 Gram-positive oxazolidinone agent; contact surface material is made of at least 50% polyolefin. |
| 12/06/2001 | US20010049382 Or nicotinic acid esters |
| 12/06/2001 | US20010049366 Topical solution formulations containing an antibiotic and a corticosteroid |
| 12/06/2001 | US20010049361 Water-soluble dry compositions |
| 12/06/2001 | US20010049353 Stimulating secretion of pancreatic juices |
| 12/06/2001 | US20010049130 Carrier for pancreatic cells for transplantation into an animal body is formed with a lateral extent much greater than its thickness to enhance its diffusional capability; enhanced hormonal response to stimuli as in blood sugar levels |
| 12/06/2001 | US20010048987 Laminate; rubber modified acrylonitrile- methyl acrylate copolymer |
| 12/06/2001 | US20010048947 Drug delivery |
| 12/06/2001 | US20010048946 Drug in water soluble polymer matrix |
| 12/06/2001 | US20010048945 Sustained drug release |
| 12/06/2001 | US20010048944 Antibiotic product, use and formulation thereof |
| 12/06/2001 | US20010048943 Osmotic device containing venlafaxine and an anti-psychotic agent |
| 12/06/2001 | US20010048940 Supplying genes into mammal cells |
| 12/06/2001 | US20010048939 Cationic reagents of transfection |
| 12/06/2001 | US20010048938 TTS containing an antioxidant |
| 12/06/2001 | US20010048936 Multilayer |
| 12/06/2001 | US20010048931 Oral administering |
| 12/06/2001 | US20010048925 Core or carrier adjuvant for vaccine |
| 12/06/2001 | US20010048914 Radioactive therapeutic liposomes |
| 12/06/2001 | DE10050267A1 Dental and/or oral cleaning agent, such as toothpaste, tooth gel, tooth powder, medicinal chewing gum, mouthwash, mouth powder, mouth pill or toothpick, comprises psychopharmaceutical |
| 12/06/2001 | DE10026791A1 Mikronisiertes Bariumsulfat Micronized barium sulfate |
| 12/06/2001 | DE10026699A1 Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage Formulation of heparin, glycosaminoglycan or Heparinoidbasis and use of the formulation and the formulation base |
| 12/06/2001 | DE10026698A1 Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung Selfemulsifiable drug formulation and use of this formulation |
| 12/06/2001 | DE10025971A1 Transdermales therapeutisches System mit verminderter Tendenz zur Wirkstoffkristallisation Transdermal therapeutic system with reduced tendency for drug crystallization |
| 12/06/2001 | DE10025970A1 Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer Estrogenhaltiges plaster with an active substance reservoir based on ethylcellulose and an ethylene-vinyl acetate-vinylpyrrolidone copolymer |
| 12/06/2001 | DE10025644A1 Schmales bandförmiges transdermales therapeutisches System zur Applikation von Wirkstoffen direkt über dem arteriellen oder venösen Gefäßsystem Narrow band-shaped transdermal therapeutic system for the administration of active ingredients directly through the arterial or venous vascular system |
| 12/06/2001 | DE10025328A1 Acetylsalicylsäure enthaltendes superfizielles therapeutisches System zur Behandlung von Hautschmerzen Superficial therapeutic system containing acetylsalicylic acid for treating skin pain |
| 12/06/2001 | DE10024413A1 Pharmazeutische und/oder kosmetische Zubereitung Pharmaceutical and / or cosmetic preparation |
| 12/06/2001 | DE10024407A1 Vorrichtung zur Beschichtung von Granulaten und Kernen Apparatus for the coating of granulates and seeds |
| 12/06/2001 | DE10017795A1 Curing or alleviating hemorrhoids or alleviating varicose veins, by direct application of hot supersaturated salt solution after cooling |
| 12/06/2001 | CA2413990A1 Acne-treating composition |
| 12/06/2001 | CA2413188A1 Petrolatum-based nose ointment |
| 12/06/2001 | CA2411666A1 Methods and compositions for producing a neurosalutary effect in a subject |
| 12/06/2001 | CA2410882A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 12/06/2001 | CA2410650A1 Medicament for combating respiratory depression |
| 12/06/2001 | CA2410589A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine |
| 12/06/2001 | CA2410265A1 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | CA2409188A1 Polyubiquitin based hydrogel and uses thereof |
| 12/06/2001 | CA2408793A1 Use of a celecoxib composition for fast pain relief |
| 12/06/2001 | CA2380769A1 Transdermal delivery of lasofoxifene |
| 12/06/2001 | CA2375875A1 Low emulsifier multiple emulsions |
| 12/05/2001 | EP1160018A2 Method and apparatus for fine particle formation |
| 12/05/2001 | EP1160005A1 Nanoemulsion based on anionic polymers, and uses thereof especially in the cosmetic, dermatological, pharmaceutical and/or ophthalmic fields |
| 12/05/2001 | EP1159975A2 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159974A1 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159966A2 Composition for the treatment of psoriasis |
| 12/05/2001 | EP1159962A1 Liposome preparations |
| 12/05/2001 | EP1159960A1 Pharmaceutical compositions based on diclofenac |
| 12/05/2001 | EP1159958A1 Vaseline-based nasal ointment |
| 12/05/2001 | EP1159957A2 Device for the local administration of solid or semi-solid formulations, sustained release formulations for parenteral administration and process of preparation |
| 12/05/2001 | EP1159955A1 Carrier particles for use in dry powder inhalers |
| 12/05/2001 | EP1159882A2 Coating material and coated powder |
| 12/05/2001 | EP1159878A1 Intraoral stimulating implement |
| 12/05/2001 | EP1159409A1 Introducing a biological material into a patient |
| 12/05/2001 | EP1159328A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 12/05/2001 | EP1159278A2 Inhibitors of aspartyl protease |
| 12/05/2001 | EP1159061A1 Chemical method for making pyrithione particle dispersions |
| 12/05/2001 | EP1159049A1 Responsive gels and methods of use thereof |
| 12/05/2001 | EP1159012A1 Encapsulated cells containing an amplified expression vector as a drug delivery device |
| 12/05/2001 | EP1159009A2 Use of niaouli essential oil as transdermal permeation enhancer |
| 12/05/2001 | EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds |
| 12/05/2001 | EP1158993A1 Bacterial membrane fractions with adjuvant effect |
| 12/05/2001 | EP1158988A2 Corticosteroid formulation |
| 12/05/2001 | EP1158979A2 Compositions of remifentanil |
| 12/05/2001 | EP1158970A1 Combinations of formoterol and a tiotropium salt |
| 12/05/2001 | EP1158967A1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| 12/05/2001 | EP1158966A1 Bacterial ghosts as carrier and targeting vehicles |
| 12/05/2001 | EP1158965A2 Capsule system |
| 12/05/2001 | EP1158964A1 Edible coating composition |
| 12/05/2001 | EP1158963A1 Controlled-release compositions of betahistine |
| 12/05/2001 | EP1158962A1 Method for producing solid dosage forms containing cyclodextrin |
| 12/05/2001 | EP1158961A1 Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds |